(2026). Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’. Endocrinology, Diabetes & Metabolism.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’."
Endocrinology, Diabetes & Metabolism 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’."
Endocrinology, Diabetes & Metabolism, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.